Projected Income Statement: CKD Corporation

Forecast Balance Sheet: CKD Corporation

Forecast Balance Sheet - CKD Corporation
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 -16,618 -9,943 9,226 468 -8,237 -15,463 -17,003 -27,412
Change - 40.17% 192.79% -94.93% -1,860.04% -87.73% -9.96% -61.22%
Announcement Date 5/13/22 5/12/23 5/10/24 5/13/25 5/15/26 - - -
1JPY in Million
Estimates

Cash Flow Forecast: CKD Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 9,596 11,447 22,128 5,023 2,826 8,000 12,000 12,333
Change - 19.29% 93.31% -77.3% -43.74% 183.09% 50% 2.78%
Free Cash Flow (FCF) 1 3,808 -1,743 -12,632 13,117 12,006 10,044 15,736 18,315
Change - -145.77% -624.73% 203.84% -8.47% -16.34% 56.67% 16.39%
Announcement Date 5/13/22 5/12/23 5/10/24 5/13/25 5/15/26 - - -
1JPY in Million
Estimates

Forecast Financial Ratios: CKD Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 16.73% 17.43% 14.82% 16.44% 16.87% 18.99% 19.07% 18.95%
EBIT Margin (%) 12.57% 13.28% 9.75% 12.22% 12.44% 15.86% 16.74% 17.28%
EBT Margin (%) 12.62% 13.41% 9.6% 12.59% 12.98% 15.99% 17.02% 16.93%
Net margin (%) 8.84% 9.27% 6.2% 8.69% 8.6% 10.84% 11.45% 11.84%
FCF margin (%) 2.68% -1.09% -9.4% 8.43% 7.6% 4.98% 6.96% 7.59%
FCF / Net Income (%) 30.3% -11.79% -151.5% 97.02% 88.42% 45.94% 60.76% 64.09%

Profitability

        
ROA 11.1% 11.83% 6.62% 9.15% 9.08% 10.83% 13.92% 16%
ROE 12.1% 12.9% 6.7% 10.2% 9.4% 13.62% 14.54% 14.72%

Financial Health

        
Leverage (Debt/EBITDA) - - 0.46x 0.02x - - - -
Debt / Free cash flow - - -0.73x 0.04x - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 6.75% 7.18% 16.46% 3.23% 1.79% 3.97% 5.3% 5.11%
CAPEX / EBITDA (%) 40.34% 41.18% 111.04% 19.63% 10.61% 20.89% 27.81% 26.96%
CAPEX / FCF (%) 252% -656.74% -175.17% 38.29% 23.54% 79.65% 76.26% 67.34%

Items per share

        
Cash flow per share 1 277.2 321.1 227.1 300.8 307.9 - - -
Change - 15.82% -29.29% 32.49% 2.34% - - -
Dividend per Share 1 67 89 50 80 81 125.5 147.8 166.8
Change - 32.84% -43.82% 60% 1.25% 54.9% 17.83% 12.86%
Book Value Per Share 1 1,643 1,794 1,934 2,044 2,297 2,474 2,711 2,953
Change - 9.19% 7.75% 5.69% 12.41% 7.7% 9.56% 8.95%
EPS 1 188.6 221.8 124.9 202.5 203.2 327.7 378.5 432
Change - 17.59% -43.66% 62.06% 0.37% 61.25% 15.48% 14.14%
Nbr of stocks (in thousands) 66,644 66,692 66,737 66,773 66,818 66,834 66,834 66,834
Announcement Date 5/13/22 5/12/23 5/10/24 5/13/25 5/15/26 - - -
1JPY
Estimates
2027 *2028 *
P/E 13.3x 11.5x
PBR 1.77x 1.61x
EV / Sales 1.37x 1.22x
Yield 2.87% 3.38%

EPS & Dividend

EPS & Dividend - CKD Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - CKD Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - CKD Corporation
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - CKD Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
4,370.00JPY
Average target price
7,586.00JPY
Spread / Average Target
+73.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CKD Corporation
  1. Stock Market
  2. Stocks
  3. 6407 Stock
  4. Financials CKD Corporation